Evoke Pharma (NASDAQ:EVOK) Stock Price Crosses Below 200-Day Moving Average of $0.90

Evoke Pharma, Inc. (NASDAQ:EVOK) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.90 and traded as low as $0.43. Evoke Pharma shares last traded at $0.44, with a volume of 15,641 shares trading hands.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Evoke Pharma in a research report on Friday. They set a “sell” rating for the company.

Evoke Pharma Stock Up 5.0 %

The stock’s 50-day moving average price is $0.59 and its 200 day moving average price is $0.90. The firm has a market cap of $3.88 million, a price-to-earnings ratio of -0.20 and a beta of 0.22.

Evoke Pharma (NASDAQ:EVOK) last posted its quarterly earnings results on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share (EPS) for the quarter. Evoke Pharma had a negative return on equity of 517.99% and a negative net margin of 150.43%. The business had revenue of $1.68 million during the quarter.

About Evoke Pharma

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.